TY  - GEN
AU  - Renouf,Daniel J
AU  - Moore,Malcolm J
AU  - Hedley,David
AU  - Gill,Sharlene
AU  - Jonker,Derek
AU  - Chen,Eric
AU  - Walde,David
AU  - Goel,Rakesh
AU  - Southwood,Bernadette
AU  - Gauthier,Isabelle
AU  - Walsh,Wendy
AU  - McIntosh,Lynn
AU  - Seymour,Lesley
TI  - A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer
SN  - 1573-0646
PY  - 2012///0611
KW  - Administration, Oral
KW  - Aged
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Benzodioxoles
KW  - Canada
KW  - Deoxycytidine
KW  - Disease Progression
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Infusions, Intravenous
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Pancreatic Neoplasms
KW  - drug therapy
KW  - Protein Kinase Inhibitors
KW  - Quinazolines
KW  - Treatment Outcome
KW  - Tumor Burden
KW  - drug effects
KW  - src-Family Kinases
KW  - antagonists & inhibitors
KW  - Gemcitabine
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s10637-010-9611-3
ER  -